Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt

Gene therapy for individuals infected with HIV has the potential to provide a once-only treatment that will act to reduce viral load, preserve the immune system, and mitigate cumulative toxicities associated with highly active antiretroviral therapy (HAART). The authors have been involved in two cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuyasu, Ronald T., Zack, Jerome A., Macpherson, Janet L., Symonds, Geoff P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116533/
https://www.ncbi.nlm.nih.gov/pubmed/21716651
http://dx.doi.org/10.4061/2011/393698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116533/
https://www.ncbi.nlm.nih.gov/pubmed/21716651
http://dx.doi.org/10.4061/2011/393698

Ejemplares similares